MPI-5017

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameMPI-5017

Drug Alias NameVinblastine/epinephrine injectable gel

ClassificationOther

Mechanisms of ActionTubulin inhibitors

TargetsTubulin

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesChiron Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesChiron Corp

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A